Friday, December 14, 2012 6:59:47 AM
"Ontario Securities Commission
20 Queen St. W.
Box 55, Suite 1900
Toronto, ON M5H 3S8
FOR IMMEDIATE RELEASE
December 12, 2012
INVESTOR ALERT – EMERGING WORLD PHARMA, INC.
TORONTO – The Ontario Securities Commission (OSC) is warning Ontario investors to exercise caution in any dealings with representatives of Emerging World Pharma, Inc. (“Emerging World”).
While Emerging World represents itself to be headquartered in Sunyani, Ghana, its officers and director are residents of Ontario and its shares were traded on the over-the-counter market in the United States.
On December 6, 2012, the U.S. Securities and Exchange Commission (SEC) suspended trading in the shares of Emerging World , noting that “questions have arisen concerning the adequacy and accuracy of press releases and other public statements concerning Emerging World’s business operation and financial condition.”
Trading in the shares of Emerging World has been suspended for a period of 10 days, ending at 11:59 p.m. EST on December 19, 2012.
The mandate of the OSC is to provide protection to investors from unfair, improper or fraudulent practices and to foster fair and efficient capital markets and confidence in capital markets. Investors are urged to check the registration of any person or company offering an investment opportunity and to review the OSC’s investor materials available at www.osc.gov.on.ca
If you have any questions or information relating to this matter, please contact the OSC Contact Centre at 1-877-785-1555."
http://www.osc.gov.on.ca/en/NewsEvents_nr_20121212_osc-ia-emerging-world-pharma.htm?RSS=HLEN&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+rss_osc_headlines_en+%28OSC%3A++Headlines%29
"It is difficult to get a man to understand something, when his salary depends upon his not understanding it."
Upton Sinclair
"Nobody ever went broke underestimating the intelligence of the American public."
H. L. Mencken
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM